Thursday, July 26, 2007 2:34:15 AM
I read some your posts yesterday and I did not have the time to respond to you like I wanted. So I copied your post to later respond to maybe help you out.
For every situation within a particular stock’s scenario that exists, there is evidence that could justify the pros and the cons of why one would be right and/or wrong in their thoughts. Each stock has its own variables which creates a trading scenario not new to someone within the market.
I say this because you were hinting towards the price remaining stagnant to a decline if no news was going to be released. News was released and WNSH traded as if no news was released considering the magnitude of the news released today/yesterday.
Sometimes we here within these message boards have an affect on the price of a stock, but sometimes we don’t. One thing that is for sure, WNSH will move when it’s time for it to move which I think could be any day now for support outside of us here posting. Ok, maybe sometimes we here might mean a little.
As for moving with news, news might or might not make WNSH move. It depends on the news, but also on many other variables too. My point with this is to take GRUS for an example. GRUS moved on really no news from .0003/4 per share to .012 per share on no news with an OS of 4,232,455,818 shares. OK, I think it had one PR while it was in the .002+ range, but it dipped back down in the .001+ per share range after the PR before going over .01+ per share. It was even confirmed that the company still might be doing a reverse split. Still, what we shareholders thought had nothing to do with the movement of the price.
I think the same, similar, or better exist here with WNSH. I personally would relax and understand that today WNSH graduated from a trade to an investment in my opinion. I would just hate for you to sell for the wrong reasons and miss out on the potential gains here with WNSH in my opinion.
v/r
Sterling
Sterling's Trading & Investing Strategies:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=29867262
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM